167 related articles for article (PubMed ID: 25890430)
1. Soy β-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver disease.
Wanezaki S; Tachibana N; Nagata M; Saito S; Nagao K; Yanagita T; Kohno M
Obes Res Clin Pract; 2015; 9(2):168-74. PubMed ID: 25890430
[TBL] [Abstract][Full Text] [Related]
2. Soy β-Conglycinin Peptide Attenuates Obesity and Lipid Abnormalities in Obese Model OLETF Rats.
Wanezaki S; Saito S; Inoue N; Tachibana N; Shirouchi B; Sato M; Yanagita T; Nagao K
J Oleo Sci; 2020; 69(5):495-502. PubMed ID: 32378551
[TBL] [Abstract][Full Text] [Related]
3. Soy β-conglycinin improves glucose uptake in skeletal muscle and ameliorates hepatic insulin resistance in Goto-Kakizaki rats.
Tachibana N; Yamashita Y; Nagata M; Wanezaki S; Ashida H; Horio F; Kohno M
Nutr Res; 2014 Feb; 34(2):160-7. PubMed ID: 24461318
[TBL] [Abstract][Full Text] [Related]
4. Dietary β-Conglycinin Modulates Insulin Sensitivity, Body Fat Mass, and Lipid Metabolism in Obese Otsuka Long-Evans Tokushima Fatty (OLETF) Rats.
Kawabeta K; Hase-Tamaru S; Yuasa M; Suruga K; Sugano M; Koba K
J Oleo Sci; 2019 Apr; 68(4):339-350. PubMed ID: 30867392
[TBL] [Abstract][Full Text] [Related]
5. Effective Food Ingredients for Fatty Liver: Soy Protein β-Conglycinin and Fish Oil.
Yamazaki T; Li D; Ikaga R
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567368
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of β-conglycinin on renal function and nephrin expression in early streptozotocin-induced diabetic nephropathy rats.
Yang HY; Wu LY; Yeh WJ; Chen JR
Br J Nutr; 2014 Jan; 111(1):78-85. PubMed ID: 23803175
[TBL] [Abstract][Full Text] [Related]
7. Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption.
Moriyama T; Kishimoto K; Nagai K; Urade R; Ogawa T; Utsumi S; Maruyama N; Maebuchi M
Biosci Biotechnol Biochem; 2004 Feb; 68(2):352-9. PubMed ID: 14981298
[TBL] [Abstract][Full Text] [Related]
8. Serum lipid-improving effect of soyabean β-conglycinin in hyperlipidaemic menopausal women.
Ma D; Taku K; Zhang Y; Jia M; Wang Y; Wang P
Br J Nutr; 2013 Nov; 110(9):1680-4. PubMed ID: 23561330
[TBL] [Abstract][Full Text] [Related]
9. Soya protein β-conglycinin ameliorates fatty liver and obesity in diet-induced obese mice through the down-regulation of PPARγ.
Li D; Ikaga R; Yamazaki T
Br J Nutr; 2018 Jun; 119(11):1220-1232. PubMed ID: 29770757
[TBL] [Abstract][Full Text] [Related]
10. Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein.
Yamazaki T; Kishimoto K; Miura S; Ezaki O
J Nutr Biochem; 2012 Feb; 23(2):123-32. PubMed ID: 21447441
[TBL] [Abstract][Full Text] [Related]
11. The α' subunit of β-conglycinin and various glycinin subunits of soy are not required to modulate hepatic lipid metabolism in rats.
Chatterjee C; Liu J; Wood C; Gagnon C; Cober ER; Frégeau-Reid JA; Gleddie S; Xiao CW
Eur J Nutr; 2018 Apr; 57(3):1157-1168. PubMed ID: 28324208
[TBL] [Abstract][Full Text] [Related]
12. β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats.
Ferreira ES; Silva MA; Demonte A; Neves VA
Lipids Health Dis; 2012 Jan; 11():11. PubMed ID: 22243700
[TBL] [Abstract][Full Text] [Related]
13. Beta-conglycinin lowers very-low-density lipoprotein-triglyceride levels by increasing adiponectin and insulin sensitivity in rats.
Tachibana N; Iwaoka Y; Hirotsuka M; Horio F; Kohno M
Biosci Biotechnol Biochem; 2010; 74(6):1250-5. PubMed ID: 20530915
[TBL] [Abstract][Full Text] [Related]
14. Soy compared with milk protein in a Western diet changes fecal microbiota and decreases hepatic steatosis in obese OLETF rats.
Panasevich MR; Schuster CM; Phillips KE; Meers GM; Chintapalli SV; Wankhade UD; Shankar K; Butteiger DN; Krul ES; Thyfault JP; Rector RS
J Nutr Biochem; 2017 Aug; 46():125-136. PubMed ID: 28605664
[TBL] [Abstract][Full Text] [Related]
15. Protective and reparative effects of peptides from soybean β-conglycinin on mice intestinal mucosa injury.
Ren J; Yang B; Lv Y; Guo S
Int J Food Sci Nutr; 2014 May; 65(3):345-50. PubMed ID: 24224901
[TBL] [Abstract][Full Text] [Related]
16. Dietary β-conglycinin prevents acute ethanol-induced fatty liver in mice.
Ikaga R; Li D; Yamazaki T
Biochem Biophys Res Commun; 2017 Nov; 493(1):542-547. PubMed ID: 28867186
[TBL] [Abstract][Full Text] [Related]
17. Soy β-conglycinin retards progression of diabetic nephropathy via modulating the insulin sensitivity and angiotensin-converting enzyme activity in rats fed with high salt diet.
Yeh WJ; Yang HY; Chen JR
Food Funct; 2014 Nov; 5(11):2898-904. PubMed ID: 25205218
[TBL] [Abstract][Full Text] [Related]
18. Effects of soybean beta-conglycinin on hepatic lipid metabolism and fecal lipid excretion in normal adult rats.
Fukui K; Kojima M; Tachibana N; Kohno M; Takamatsu K; Hirotsuka M; Kito M
Biosci Biotechnol Biochem; 2004 May; 68(5):1153-5. PubMed ID: 15170126
[TBL] [Abstract][Full Text] [Related]
19. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M
J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265
[TBL] [Abstract][Full Text] [Related]
20. Chronic NOS inhibition accelerates NAFLD progression in an obese rat model.
Sheldon RD; Padilla J; Jenkins NT; Laughlin MH; Rector RS
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G540-9. PubMed ID: 25573175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
